Drugs / Sanofi Trivalent Seasonal Influenza Vaccine
Sanofi Trivalent Seasonal Influenza Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03777163 | Apr 2019 → Jan 2020 | influenza | Butantan Institute | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sanofi Trivalent Seasonal Influenza Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03777163 ↗ |
| Modality | Vaccine | “Sanofi Trivalent Seasonal Influenza Vaccine” NCT03777163 ↗ |
| Route | Intramuscular | “via intramuscular injection” NCT03777163 ↗ |